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The effects of all-trans retinoic acid (RA) in 0.05%, 
0.025% and 0.005% concentrations on ultraviolet (UV) 
induced carcinogenesis was investigated in the skin of 
Uscd strain hairless mice. A carcinogenic amount ofUV 
energy was delivered over the 12-mo period of the study. 
The 0.025% and 0.005% RA solutions did not alter the 
development of cutaneous cancers. However, the 0.05% 
RA concentration significantly inhibited the tumor for-
mation in this study. 
All-trans retinoic acid (RA) is a biologically active derivative 
of vitamin A which has been shown to exhibit antineoplastic 
effects on certain experimentally induced and naturally occur-
ring tumors [1-5]. However information concerning the effects 
of this chemical on UV -induced cancer formation is somewhat 
sparse. In a previqus study one of us (JE) reported that a 0.3% 
concentration of RA in a cream base enhanced UV carcinogen-
esis induced by exposures to a high-pressure mercury arc source 
3 times a week [6]. Since this was an irritating and toxic 
concentration of the chemical the irritancy factor was consid -
ered the most likely mechanism of the effect. Subsequently 
Forbes et al [7] noted that essentially nonirritating 0.01% and 
0.001 % concentrations of RA in a methanol base also signifi-
cantly enhanced UV carcinogenesis using exposures from a 
solar simulator and a 7 day a week schedule for both modalities. 
The present study was designed to examine the effects of low 
concentrations of RA on mercury arc induced cancer formation. 
MATERIALS AND METHODS 
Experimen.tal Animals 
In th is study 148 random-bred 3- to 4-mo old Uscd strain hairless 
mice were housed in metal cages and fed on unrestricted quantities of 
Wayne Lab Blox and wate)". Visible light exposure was minimal excepl. 
during treatment and examination proc~dures. 
Light Source 
A Hanovia air-cooled hot quartz contact lamp produced UVB energy, 
.25 mJ /cm2/sec (280-320 nm) at a distance of 3.4 cm. A Hanovia UV 
meter (Model AV-971) was used to measure the applied energy. 
Chemicals' 
RA concentrations of 0.05%, 0.025% and 0.005% were dissolved in a 
vehicle containing (BHT) 0.1%, 95% alcohol 59.6% and polyethylene 
glycol 40.2% (the base alone for group 4 contained the BHT 0.1%, 95% 
alcohol 59.6% and polyethylene glycol 40.3%). The RA solutions with 
the diluent were applied to the backs of the mice with a 1 ml syringe. 
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Procedure 
The mice were divided into 4 groups. Group 1 (43 mice) received 
1.25 mJ /cm2 of UVB energy to the posterior half of the back followed 
by 0.1 ml of the 0.05% HA solution applications to the whole back 3 
times a week (Monday, Wednesday and Friday) for the duration of the 
study. Group 2 (35 mice), group 3 (35 mice) and group 4 (35 mice) 
received UV followed by applications of 0.025% RA, 0.005% RA and 
diluent applications as in group 1 for the duration of the study. 
The mice were examined at regular intervals and tumors greater 
than 4 mm", 50 mm" and 100 mm" were tabu lated. The tumors were 
measured in 2 diameters at right angles and the protrusion above the 
surface was also measured. These sizes were chosen to allow comparison 
of tumor development and growth with previous reports on UV and 
chemical carcinogenesis [8-11). 
RESULTS 
Macroscopic Observations 
The mice receiving the applications of 3 RA concentrations 
developed mild erythema and desquamation in the irradiated 
and non irradiated sites in the first week of the study. This was 
not noted thereafter and no differences in irradiated and non-
irradiated sites between any of the groups was noted t hereafter. 
In addition, we could not detect any gross evidence of systemic 
toxicity in the 4 groups. 
Tumor Onset 
Two mice developed 1 tumor apiece greater than 4 mm3 in 
the nonirradiated diluent treated skin (group 4) at 40 and 45 
weeks and 1 mouse in group 2 receiving 0.025% RA applications 
developed 1 tumor greater than 4 mm:! in the nonirradiated skin 
at 23 weeks. These tumors remained small growths. 
In the UV irradiated site the first tumors greater than 4 mm3 
occurred by 16 weeks in groups 1, 3 and 4 and by 20 weeks in 
group 2. They reached sizes of 50 and 100 mm3 by 23 to 26 
weeks in groups 1, 2 and 3 and by 20 weeks in group 4. Histologic 
examination revealed that the tumors greater than 50 mm3 
were squamous cell carcinomas. 
Life table analysis (actuarial analysis) was performed on the 
tumor development data for tumor sizes greater than 4, 50 and 
100 mm" comparing the mice receiving RA applications and UV 
with those receiving diluent applications and UV. From these 
analyses distribution CUl'ves representing cumulative probabil-
ities of developing tumors were examined (Tables 1, II, and ill). 
As noted, few tumors occurred before 20 weeks in any of the 
groups. The bulk of tumors greater than 4, 50 and 100 mm3 
occurred by 40 to 45 weeks in group 1 (0.05% RA plus UV) 
3 ' 
whereas most of the smaller tumors (>4mm' ) appeared be-
tween 25 and 30 weeks and most of the larger ones (>50 and 
100 mm:l) appeared between 30 and 35 weeks in group 4 (diluent 
plus UV). The tumor development in groups 2, (0.025% RA plus 
UV) and 3 (0.005% RA and UV) simulated that in group 4. 
Thus the tumors appeared later and grew slower in the mice 
treated with 0.05% RA. 
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A Mantel-Haenszel [12,13] 1 degree freedom continuity-cor-
rected X 2 was computed for each tumor size allowing simulta-
neous comparison over all the contingency tables of the differ-
imces in tumor development probabilities for comparing groups 
1, 2 and 3 with control group 4. All 3 summary X 2s for compar-
ison of groups 1 and 4 statistically significant (tumor> 4 mms 
X2 = 10.99, P < 0.001; tumor> 50 mm" X2 = 6.1, 0.01 < P < 
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TABLE I. Cumulative probabilities of developing a tumor (l .px)" all· trans retinoic acid (RA) 0.05% (group 1, n 43) vs control (groups 4, n 35) 
l' > 4 l' > 50 l' > 100 
Uy' Uy+ Uy+ UY ' UY' UY' 
RA .05% Diluent. RA .0,';% Diluent. RA .05% Diluent 
0-5 wks .000 .000 .000 .000 .000 .000 
5-10 .000 .000 .000 .000 .000 .000 
10-15 .000 .000 .000 .000 .000 .000 
15-20 .049 .114 .000 .000 .000 .000 
20-25 .100 .314 .026 .057 .026 .057 
25-30 .233 .600 .079 .371 .079 .314 
30-35 .488 .778 .295 .605 .214 .577 
35-40 .545 .84 1 .502 .731 .414 .698 
40-45 .659 .968 .644 .832 .538 .799 
P < 0.001" p < 0.025 > 0.01" p < 0.01 > 0.005" 
" Computed by li fe table method-Each entry is I-cumulative probabili ty of not developing a tumor by time x, i.e. 1-P, . 
b Differences in t ime to tumor development between the RA + UV group and the control group (diluent + UV) for each tumor size was tested 
by the Mantel-Haenszel summary chi-square method [12, 13]. 
TABLE II. Cumulative probabilities of developing a tumor (I·PA)" all· trans retinoic acid (RA) 0.025% (group 2, n 35) vs control (group 4, n 35) 
1' > 4 l' > 50 l' > 100 
UY' UY' UY' Uy· UV' UV' 
RA .02:;% Diluent RA .025% Diluent RA .025% Diluent. 
0-5 wks .000 .000 .000 .000 .000 .000 
5-10 .000 .000 .000 .000 .000 .000 
10-15 .000 .000 .000 .000 .000 .000 
15-20 .030 .114 .000 .000 .000 .000 
20-25 .121 .314 .061 .057 .030 .057 
25-30 .460 .600 .277 .371 .276 .314 
30-35 .730 .778 .638 .605 .572 .577 
35-40 .812 .84 1 .905 .731 .907 .698 
40-45 .812 .968 .969 .832 .969 .799 
p = ns" p = ns" p = nsb 
a Computed by li fe table method-Each entry is I-cumulative probability of not developing a tumor by time x, i.e. 1-Px • 
b Differences in time to tumor development between the RA + UV group and the control group (diluent + UV) for each tumor size was tested 
by t he Mantel-Haenszel summary chi,sQuare method [12, 13]. 
TABLE III. Cumulative probabilities of developing a tum.or (J ·P.,.)" all-trans retinoic acid (RA) .005% (group 3, n 35) vs control (group 4, n 35) 
l' > 4 l' > 50 l' > 100 
UY+ UY" UY+ UY+ UY+ UY· 
RA .005% Diluent RA .005% Diluent RA .005% Diluent 
0-5 wks .000 .000 .000 .000 .000 .000 
5-10 .000 .000 .000 .000 .000 .000 
10-15 .000 .000 .000 .000 .000 .000 
15-20 .029 .114 .000 .000 .000 .000 
20-25 .286 .314 .029 .057 .000 .057 
25-30 .572 .600 .372 .371 .286 .314 
30-35 .808 .778 .577 .605 .577 .577 
35-40 .936 .841 .849 .731 .849 .698 
40-45 .936 .968 .909 .832 .909 .799 
P = ns" P = ns" P = nsb 
a Computed by life table method-Each entry is I-cumulative probability of not developing a tumor by time x, i.e. I-Px• 
b Differences in time to tumor development between the RA + UV group and the control group (diluent + UV) for each tumor size was tested 
by the Mantel-Haenszel summary chi-square method [12, 13]. 
0.025; and tumor> 100 mm3 X2 = 7.82, 0.005 < p < 0.01). The 
tumor development in groups 2 and 3 was not statistically 
different than that noted in the control group 4 with p values 
ranging from p > 0.9 to p > 0.25. 
Thus we conclude that the 0.05% RA plus UV induced tumors 
more s'iowly than the diluent plus UV. Also we conclude that 
0.025% RA and 0.005% RA did not significantly inhibit UV-
induced tumor formation. 
DISCUSSION 
These results indicate that 0.025% and 0.005% concentrations 
of RA had no influence on UV-induced cutaneous cancer for-
mation under the circumstances of this study. However the 
0.05% concentration of the chemical did statistically signifi-
cantly inhibit this photocarcinogenesis. These findings are in 
contrast to our previous findings with the irritating and toxic 
0.3% concentration [6] and the essentially nontoxic 0.01% and 
0.001 % levels used by Forbes, Urbach, and Davies [7]. 
Davies reported at a recent "Retinoic Acid and Photocarcin-
agenesis" Workshop [14J that nontoxic amounts of RA pro-
moted UV carcinogenesis using a 2-stage system. In this study 
Davies and co-workers used irradiation from FS-40 sunlamps 
as the initiator and topical RA as the promoter after discontin-
uing the irradiation. They noted that RA had no promoting 
effects when benz (a) pyrene was used as the initiator. Also 
Forbes [14J reported that oral RA had no effect on photocar-
cinogenesis. As noted in the introduction, RA can inhibit chem-
ically induced cancer formation . However it can also stimulate 
this process [15]. In addition, growth stimulation of cultw-ed 
epidermal cells and the induction of plasminogen activator 
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activity by RA has been reported [16,17). The RA effect on 
plasminogen activator was syn el'gistic with sarcoma virus trans-
formation and phorbol ester effects, Thus it appears that the 
ch emical can influence car cinogen esis in contrasting ways de-
pending upon the design of t he study. 
The m ech anism of the inhibition of photocarcinogenesis by 
0.05% RA applications in this study is not clear. The diluent 
conta ined an antioxident a nd such ch emicals h ave been shown 
to dep ress UV-induced tumor formation [18]. However, the 
0.05% RA must have had at least an added effect to explain the 
results noted . 
These inhibitory effects may relate to the recent findings 
indicating th at the potent chemical promoter 12-0-tetradeca-
noyl-phorbol-13-acetate (TPA) leads to a m arked increase in 
ornithine decarboxylase (ODC ) activity. This enzyme stimula-
t ion correla tes with the tumor promoting abilities of the TP A 
[19]. RA inhibits the stimulation of ODC activity a nd the 
inhibition is associated with a reduction in tumor production 
[20,21)' Subsequently it was noted that UV also induces an 
increase in ODC activity (22). Lowe also reported that RA 
r educed this response under certain circumstan ces [14]. How-
ever there is some question wheth er the m echanism responsible 
for t h e ODe increase is the sam e following TP A and UV 
stimulation. 
Of interest, chronic applications of 0.05% RA for 10 and 22 
weeks inhibits the expected UV-induced acute d epression of 
DNA syn t h esis in epidermal basal cells that occurs 4 hr postu'-
radiation and the acceleration of DNA synthesis a nd epidermal 
h yperplasia that occurs 48 hr after UVB exposm es in the 
hairless mouse skin [23]. Topical RA h as also been shown to 
inhibit DNA synthesis in psoriatic epidermis [241 and MCA 
induced DNA synthesis and hyperplas ia in prostate organ 
cultUl'e [25]. Iversen has also noted that RA inhibited UV-
induced endogenous dehyrogenase activity in the epidermis as 
measUl'ed by the t~trazolium-reduction m ethod (14). Increased 
d eh y drogen ase activity has been noted after exposure to ioniz-
ing ra diation and ch emical carcinogens but not noncarcinogenic 
cutaneous irritants. This technique forms the basis for the 
tetrazolium test for skin carcinogenesis [26]. 
Other possible mechanisms reported include inhibition 
through control o f ceU differentiation [4,271, enhancement of 
cell m ediated cytotoxicity [281, perhap s through killer T-cell 
stimulation [291, la bilizing lysosomal m embranes (30], a nd in-
hibition of th e transforming effects of endogenous growth fac-
tors [31). 
Whether one, combinations of several , or none of these m ech-
anisms relate to the inhibition of UV carcinogenesis noted in 
this study remains to be determined. 
Statistical analysis was provided by Calvin Zippin and Kenneth 
Resser of the Cancer Research Institute of the University of California, 
San Francisco. 
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